Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Willinger

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Mbio|May 20, 2026
Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection modelAlexander M Aldejohann, Nadja Thielemann, Aina Martinez Zurita, et al.
Critical Care (London, England)|May 1, 2015
Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patientsSusanne Eigl, Juergen Prattes, Michaela Lackner, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of actionMartin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
Allergologie Select|May 17, 2024
AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001Julia Hurraß, Birger Heinzow, Sandra Walser-Reichenbach, et al.
Pneumologie (Stuttgart, Germany)|October 18, 2024
[Medical clinical diagnostics for indoor mould exposure - Update 2023 (AWMF Register No. 161/001)]Julia Hurraß, Birger Heinzow, Sandra Walser-Reichenbach, et al.
Medical Mycology|March 25, 2017
Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?C Oliver Morton, P Lewis White, Rosemary A Barnes, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Journal of Clinical Microbiology|January 2, 2025
Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardizationSteffi Rocchi, Emeline Scherer, P Lewis White, et al.
The Journal of Infection|July 18, 2024
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort StudyJon Salmanton-García, Oliver A Cornely, Jannik Stemler, et al.
The Journal of Infection|August 7, 2023
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III studyMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Karin Meinike Jørgensen, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Mbio|May 20, 2026
Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection modelAlexander M Aldejohann, Nadja Thielemann, Aina Martinez Zurita, et al.
Critical Care (London, England)|May 1, 2015
Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patientsSusanne Eigl, Juergen Prattes, Michaela Lackner, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of actionMartin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
Allergologie Select|May 17, 2024
AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001Julia Hurraß, Birger Heinzow, Sandra Walser-Reichenbach, et al.
Pneumologie (Stuttgart, Germany)|October 18, 2024
[Medical clinical diagnostics for indoor mould exposure - Update 2023 (AWMF Register No. 161/001)]Julia Hurraß, Birger Heinzow, Sandra Walser-Reichenbach, et al.
Medical Mycology|March 25, 2017
Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?C Oliver Morton, P Lewis White, Rosemary A Barnes, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2019
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)Jon Salmanton-García, Danila Seidel, Philipp Koehler, et al.
Journal of Clinical Microbiology|January 2, 2025
Interlaboratory assays from the fungal PCR Initiative and the Modimucor Study Group to improve qPCR detection of Mucorales DNA in serum: one more step toward standardizationSteffi Rocchi, Emeline Scherer, P Lewis White, et al.
The Journal of Infection|July 18, 2024
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort StudyJon Salmanton-García, Oliver A Cornely, Jannik Stemler, et al.
The Journal of Infection|August 7, 2023
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III studyMaiken Cavling Arendrup, Sevtap Arikan-Akdagli, Karin Meinike Jørgensen, et al.
Pageof 11